AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


After the COVID-19 pandemic put unprecedented financial pressure on clinical laboratories and in vitro diagnostics (IVD) companies, these specific companies received $5.3 billion in capital alone in 2020. Will that level of investment remain? And what happens going forward?
A new guidance document on laboratory investigation of acute kidney injury (AKI) released by the AACC Academy aims to better guide clinicians and laboratorians in their evaluations of AKI, with the goal of promoting best practices to improve patient outcomes.

Ask the Expert

Bench Matters

To boost efficiency with urinalysis, many laboratories have implemented reflex testing approaches. If paired with carefully designed electronic order options and clinical decision-support systems, this strategy has the potential to optimize test utilization, improve result turnaround times, and reduce laboratory costs for reagents and labor.

Industry Playbook

Regulatory Roundup

Special Supplement